ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GILD announcements Gilead Sciences, Inc. announcements and dividends declared USA

Gilead Sciences, Inc. Complete list of announcements declared & dividend announcements by Gilead Sciences, Inc. GILD

Gilead Sciences, Inc. GILD listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Gilead Sciences, Inc. GILD

Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
Gilead Sciences (GILD) closed at .78 in the latest trading session, marking a -1.58% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.27% for the day. Elsewhere, the Dow gained 0.43
Announcement as on 14 December 2023

Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the latest trading day at .02, indicating a +1.24% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.41%. Meanwhile, the Dow gained
Announcement as on 08 December 2023

Gilead Sciences Presents Three-year Outcomes From BICSTaR Study With Biktarvy
(RTTNews) - Gilead Sciences, Inc. (GILD) reported new long-term real-world data from the BICSTaR study highlighting the safety and efficacy profile of Biktarvy as a treatment regimen for a broad range of people with HIV, including those with a prior treat
Announcement as on 19 October 2023

5 Reasons Gilead Sciences is a Better Buy Than You Think
Shares of Gilead Sciences (NASDAQ: GILD) are down roughly 20% from their highs in 2023 and, like other stocks in correction this year, are showing signs of a bottom. The price pressure in 2023 is due primarily to the COVID-19 cliff; Gilead’s business
Announcement as on 10 October 2023

: Gilead Sciences says FDA has approved Veklury in COVID patients with severe kidney disease
Gilead Sciences Inc. GILD said Friday the U.S. Food and Drug Administration has approved the use of its Veklury, or remdesivir, for patients with severe renal impairment, including those on dialysis. Veklury is now the only approved COVID antiviral for peo
Announcement as on 14 July 2023

Announcements by Gilead Sciences, Inc. first page | Next page | Prev page |

GILD Gilead Sciences, Inc. current price & indicator signals

Moving Averages for Gilead Sciences, Inc.

  • 5Day Average: 162.68
  • 12Day Average: 158.61
  • 20Day Average: 154.46
  • 50Day Average: 150.88
  • 100Day Average: 141.22
  • 150Day Average: 138.64
  • 200Day Average: 139.93

GILD Indicators & signals

Indicator MACD (12,26,9)

159.37, 155.07, 2.92
Indicator MACD is in positive zone

Indicator ADX (14)

56.97, 43.78, 12
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GILD Gilead Sciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 170.80 169.00 to 175.65 3.12% 1.04 times
29 Thu Oct 2026 165.63 160.86 to 165.70 4.04% 0.77 times
28 Wed Oct 2026 159.20 156.04 to 160.83 0.08% 0.88 times
27 Tue Oct 2026 159.08 155.76 to 159.28 0.25% 0.88 times
26 Mon Oct 2026 158.69 157.52 to 159.69 1.7% 1.08 times
23 Fri Oct 2026 156.04 155.76 to 157.65 -0.73% 1.08 times
22 Thu Oct 2026 157.19 153.00 to 157.42 2.36% 1.1 times
21 Wed Oct 2026 153.57 151.71 to 155.42 -1.9% 1.11 times
20 Tue Oct 2026 156.54 153.27 to 157.48 2.27% 0.51 times
19 Mon Oct 2026 153.07 152.92 to 157.24 -2% 1.22 times
16 Fri Oct 2026 156.19 155.62 to 157.58 -0.75% 1.38 times
15 Thu Oct 2026 157.37 156.02 to 160.51 2.49% 1.47 times

Videos related to: GILD announcements Gilead Sciences, Inc. announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GILD announcements Gilead Sciences, Inc. announcements and dividends declared USA

 

Back to top